Top

Published in:

01-04-2022 | Viewpoint

Rethinking Community Benefit Programs—A New Vision for Hospital Investment in Community Health

Authors: Pooja Chandrashekar, AB, Rebekah Gee, MD, MPH, Jay Bhatt, DO, MPH, MPA

Published in: Journal of General Internal Medicine | Issue 5/2022

Excerpt

Over the past decade, hospitals have been tasked with a growing responsibility to address the social determinants of health. One promising avenue for investment is the “community benefit” that nonprofit hospitals must provide in exchange for their tax-exempt status. However, there is significant debate around whether community benefits actually serve their purpose in improving community health. …

Chaiyachati KH, Qi M, Werner RM.Non-profit hospital community benefit spending based on local sociodemographics. J Health Care Poor Underserved. 2018;29(4):1259-1268. https://doi.org/10.1353/hpu.2018.0093. PMID: 30449744; PMCID: PMC6425942.CrossRefPubMedPubMedCentral

Rozier M, Goold S, Singh S. How Should Nonprofit Hospitals’ Community Benefit Be More Responsive to Health Disparities? AMA J Ethics. 2019 Mar 1;21(3):E273-280. https://doi.org/10.1001/amajethics.2019.273.CrossRefPubMed

Kanter GP, Nabet B, Matone M, Rubin DM. Association of State Medicaid Expansion With Hospital Community Benefit Spending. JAMA Netw Open. 2020 May 1;3(5):e205529. https://doi.org/10.1001/jamanetworkopen.2020.5529. PMID: 32469411; PMCID: PMC7260619.

“Encouraging Nonprofit Hospitals To Invest In Community Building: The Role Of IRS ‘Safe Harbors’,” Health Affairs Blog, February 11, 2014. https://doi.org/10.1377/hblog20140211.037060.

Bakken E, Kindig D, Boufford J. What “Community Building” Activities are Nonprofit Hospitals Reporting as Community Benefit?. Front Public Health Serv Syst Res 2014;3(5):e10. https://doi.org/10.13023/FPHSSR.0305.01.CrossRef

Clary A, Higgins E. Oregon and Connecticut Hold Hospitals Accountable for Meaningful Community Benefit Investment. National Academy for State Health Policy. August 29, 2019. Accessed May 5, 2021. https://www.nashp.org/oregon-and-connecticut-hold-hospitals-accountable-for-meaningful-community-benefit-investment/.

Kacik A. InDepth: Flaws in hospital community benefit reporting create knowledge vacuum. Modern Healthcare. December 1, 2018. Accessed April 27, 2021. https://www.modernhealthcare.com/article/20181201/NEWS/181119965/indepth-flaws-in-hospital-community-benefit-reporting-create-knowledge-vacuum.

Creating effective hospital-community partnerships to build a Culture of Health. Health Research & Educational Trust. August 2016. Accessed on September 27, 2021. https://www.aha.org/system/files/hpoe/Reports-HPOE/2016/creating-effective-hospital-community-partnerships.pdf.

Gaskins ASP, Steinitz R, Hacke R.Addressing the Social Determinants of Health. Center for Community Investment. November 2020. Accessed on October 7, 2021. https://centerforcommunityinvestment.org/sites/default/files/Adressing%20the%20Social%20Determinants%20of%20Health.pdf.

Title: Rethinking Community Benefit Programs—A New Vision for Hospital Investment in Community Health
Authors: Pooja Chandrashekar, AB
Rebekah Gee, MD, MPH
Jay Bhatt, DO, MPH, MPA
Publication date: 01-04-2022
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 5/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-021-07324-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2022

Disparities in Health Care Task Participation and Provider Communication by Family Caregiver Race

Respectable

When Barium Goes Down the Wrong Pipe: a Severe Case of Aspiration Pneumonitis

Nationwide Use of Telehealth Among Commercially Insured Individuals 2007–2017

Implementation and Qualitative Evaluation of a Primary Care Redesign Model with Expanded Scope of Work for Medical Assistants

Ketamine Cystitis: An Underrecognized Cause of Dysuria

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage